Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy.
Okumura T, Kimura T, Ichikawa Y, Iwadare T, Wakabayashi SI, Kobayashi H, Yamashita Y, Uchida T, Pydi SP, Tanaka N, Umemura T.
Sci Rep. : 2024 Oct 26;14(1):25584. doi: 10.1038/s41598-024-76532-5. PMID: 39461995; PMCID: PMC11513038.